Busam K - Search Results

1

Neoadjuvant relatlimab and nivolumab in resectable melanoma.

Amaria RN, Postow M, Burton EM, Tetzlaff MT, Ross MI, Torres-Cabala C, Glitza IC, Duan F, Milton DR, Busam K, Simpson L, McQuade JL, Wong MK, Gershenwald JE, Lee JE, Goepfert RP, Keung EZ, Fisher SB, Betof-Warner A, Shoushtari AN, Callahan M, Coit D, Bartlett EK, Bello D, Momtaz P, Nicholas C, Gu A, Zhang X, Korivi BR, Patnana M, Patel SP, Diab A, Lucci A, Prieto VG, Davies MA, Allison JP, Sharma P, Wargo JA, Ariyan C, Tawbi HA. Amaria RN, et al. Among authors: busam k. Nature. 2022 Nov;611(7934):155-160. doi: 10.1038/s41586-022-05368-8. Epub 2022 Oct 26. Nature. 2022. PMID: 36289334 Free PMC article. Clinical Trial.

2

Lymphatic mapping in the management of melanoma in children.

Brady MS, Weinberg H, Kraus D, Lewis JJ, Coit DG, La Quaglia MP, Busam K. Brady MS, et al. Among authors: busam k. Pediatr Dermatol. 1998 Nov-Dec;15(6):421-5. doi: 10.1046/j.1525-1470.1998.00999.x. Pediatr Dermatol. 1998. PMID: 9875961

3

Childhood melanoma survival.

Saenz NC, Saenz-Badillos J, Busam K, LaQuaglia MP, Corbally M, Brady MS. Saenz NC, et al. Among authors: busam k. Cancer. 1999 Feb 1;85(3):750-4. doi: 10.1002/(sici)1097-0142(19990201)85:3<750::aid-cncr26>3.0.co;2-5. Cancer. 1999. PMID: 10091749

4

Intradermal injection of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with metastatic melanoma recruits dendritic cells.

Nasi ML, Lieberman P, Busam KJ, Prieto V, Panageas KS, Lewis JJ, Houghton AN, Chapman PB. Nasi ML, et al. Among authors: busam kj. Cytokines Cell Mol Ther. 1999 Sep;5(3):139-44. Cytokines Cell Mol Ther. 1999. PMID: 10641571 Clinical Trial.

5

Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma.

Allen PJ, Busam K, Hill AD, Stojadinovic A, Coit DG. Allen PJ, et al. Among authors: busam k. Cancer. 2001 Sep 15;92(6):1650-5. doi: 10.1002/1097-0142(20010915)92:6<1650::aid-cncr1491>3.0.co;2-8. Cancer. 2001. PMID: 11745244

6

Value of frozen-section analysis of sentinel lymph nodes for primary cutaneous malignant melanoma.

Stojadinovic A, Allen PJ, Clary BM, Busam KJ, Coit DG. Stojadinovic A, et al. Ann Surg. 2002 Jan;235(1):92-8. doi: 10.1097/00000658-200201000-00012. Ann Surg. 2002. PMID: 11753047 Free PMC article.

7

Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors.

Lohmann CM, Coit DG, Brady MS, Berwick M, Busam KJ. Lohmann CM, et al. Am J Surg Pathol. 2002 Jan;26(1):47-55. doi: 10.1097/00000478-200201000-00005. Am J Surg Pathol. 2002. PMID: 11756768

8

Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status.

Ferrone CR, Panageas KS, Busam K, Brady MS, Coit DG. Ferrone CR, et al. Among authors: busam k. Ann Surg Oncol. 2002 Aug;9(7):637-45. doi: 10.1007/BF02574479. Ann Surg Oncol. 2002. PMID: 12167577

9

Prediction of nonsentinel lymph node status in melanoma.

Reeves ME, Delgado R, Busam KJ, Brady MS, Coit DG. Reeves ME, et al. Ann Surg Oncol. 2003 Jan-Feb;10(1):27-31. doi: 10.1245/aso.2003.03.020. Ann Surg Oncol. 2003. PMID: 12513956

10

Sentinel lymph node analysis in patients with sweat gland carcinoma.

Delgado R, Kraus D, Coit DG, Busam KJ. Delgado R, et al. Cancer. 2003 May 1;97(9):2279-84. doi: 10.1002/cncr.11327. Cancer. 2003. PMID: 12712484 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

487 results

Search Page